Your cart is currently empty!
Blog
Sofosbuvir
Active Ingredients: Sofosbuvir
Strength: 400mg
Dosage Form: Tablets
Retail Pack: 28 in a bottle
Daclatasvir + Sofosbuvir
Active Ingredients: Daclatasvir + Sofosbuvir
Strength: Daclatasvir 60 mg + Sofosbuvir 400 mg
Dosage Form: Tablets
Retail Pack: 28 in a bottle
Dolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate
Strength: Dolutegravir 50mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg
Dosage Form: Film coated Tablets
Retail Pack: 30 in a bottle
Dolutegravir
Active Ingredients: Dolutegravir
Strength: Dolutegravir 50mg
Dosage Form: Film coated Tablets
Retail Pack: 30 in a bottle
Ceftazidime & Avibactam
Active Ingredients: Ceftazidime & Avibactam
Strength: Ceftazidime 2 gm & Avibactam 0.5 gm
Dosage Form: Powder for concentrate for solution for infusion
Retail Pack: Single Dose vial
Sofosbuvir + Velpatasvir
Active Ingredients: Sofosbuvir + Velpatasvir
Strength: Sofosbuvir 400 mg + Velpatasvir 100 mg
Dosage Form: Tablets
Retail Pack: 28 in a bottle
Emtricitabine + Tenofovir
Description
This page contains brief details about the drug emtricitabine,tenofovir alafenamide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Emtricitabine + Tenofovir alafenamide is a combination of anti-retroviral drug. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). FDA approved it initially in September 2015 for its medical use.
Mechanism of Action of Ceftazidime & Avibactam
Emtricitabine and Tenofovir alafenamide are nucleoside/nucleotide analog reverse transcriptase inhibitors, exhibiting their antiviral effect by competing with natural substrates and incorporating them into viral DNA, resulting in the termination of the DNA chain.
Uses of Ceftazidime & Avibactam
Emtricitabine+Tenofovir alafenamide is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body.
Ceftazidime & Avibactam Dosage available
It is an orally available prescription drug. Your doctor will decide the dose and duration of Emtricitabine+Tenofovir alafenamide based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water. If you have difficulty swallowing the tablet, you can split it in half after consulting with your doctor.
Molnupiravir
Description
This page contains brief details about the drug molnupiravir, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Molnupiravir is an antiviral medication containing the active constituent Molnupiravir. It treats mild to moderate COVID-19 (Coronavirus disease) in people at risk for developing severe illness. COVID-19 is a highly infectious disease caused by the SARS-CoV-2 virus. Molnupiravir is not recommended for adolescents and children under the age of 18. This drug must be taken within five days of the onset of symptoms to be most effective. Molnupiravir could also provide an alternative treatment option for COVID-19 patients who cannot receive or do not respond well to existing treatments, such as monoclonal antibodies or remdesivir.
Mechanism of Action of Molnupiravir
The work of Molnupiravir is to reduce the severity of COVID-19 symptoms and prevent the virus from replicating and spreading within the body. This is accomplished by introducing errors into the genetic material of the virus, which can ultimately render it unable to reproduce and cause further harm.
Uses of Molnupiravir
Molnupiravir is an antiviral drug used to treat mild to moderate COVID-19 in high-risk adults.
Molnupiravir Dosage available
Take Molnupiravir in the dose and duration prescribed by your doctor. Swallow the medication whole with plenty of water. Do not chew or crush the capsules. This capsule can be taken with or without food. Do not skip or miss doses.
Doxorubicin
Description
This page contains brief details about the drug doxorubicin, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
The U.S. FDA-approved Doxorubicin is an anticancer medication to treat main types of cancers, on 07th September 1993.
Mechanism of Action of Doxorubicin
Doxorubicin works by interfering with the DNA in cancer cells by inserting itself into the DNA strands, which disrupts the normal structure of the DNA. This causes the DNA to break apart, leading to cell death. Additionally, doxorubicin can also cause damage to the membranes surrounding the cell’s nucleus, which further contributes to cell death.
Uses of Doxorubicin
Doxorubicin is used to treat various types of cancer, especially breast cancer, lung cancer, Malignant lymphomas, and certain types of leukemia. It is either used alone or in combination with other drugs.
Doxorubicin Dosage available
Doxorubicin is an intravenous infusion drug that is injected through the veins. Your physician will choose the dosage and administration frequency based on your medical condition because it differs for each person.
Abacavir,Dolutegravir,Lamivudine
Description
This page contains brief details about the drug abacavir,dolutegravir,lamivudine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Abacavir, Dolutegravir and Lamivudine is a combination regimen consisting of antiviral medications, which was approved for its medical use on 22nd August 2014.
Mechanism of Action of Abacavir,Dolutegravir,Lamivudine
Abacavir, Dolutegravir and Lamivudine Tablet is a combination of integrase strand transfer inhibitors and nucleoside analog reverse transcriptase inhibitors. It works by increasing the number of CD4 T cells and stimulates the immune system to fight against infections. Abacavir and Lamivudine inhibit the reverse transcriptase enzyme of the HIV-1, induce chain termination, and prevents the incorporation of viral DNA. Thereby, it reduces the viral load of HIV in the blood and decreases the severity of HIV infection.
Uses of Abacavir,Dolutegravir,Lamivudine
Abacavir, Dolutegravir, and Lamivudine have been developed to treat Human Immunodeficiency Virus (HIV-1). Abacavir, Dolutegravir, and Lamivudine Tablet is indicated as a complete regimen for treating adults and children infected with HIV 1.
Abacavir,Dolutegravir,Lamivudine Dosage available Abacavir, Dolutegravir and Lamivudine is available as film-coated tablets and oral suspension. The tablets consist of 600mg of Abacavir, 50mg of Dolutegravir, and 300mg of Lamivudine. The usual recommended dosage of this combination regimen is one tablet every day with or without food.